RSS

Archivi categoria: farmacoeconomia

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia | NEJM

Sorgente: Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia | NEJM

 

Rethinking How Antibiotics Are Prescribed: Incorporating the 4 Moments of Antibiotic Decision Making Into Clinical Practice. | Infectious Diseases | JAMA | JAMA Network

This Viewpoint summarizes recommendations from the Agency for Healthcare Research and Quality for improving antibiotic use and safety that encourages clinicians to ask if antibiotics are necessary, and to use testing and deliberate judgment to decide which ones, for how long, and if coverage can be…

Sorgente: Rethinking How Antibiotics Are Prescribed: Incorporating the 4 Moments of Antibiotic Decision Making Into Clinical Practice. | Infectious Diseases | JAMA | JAMA Network

 

Pensioni, quanto si perde con lo stop alla rivalutazione

Sorgente: Pensioni, quanto si perde con lo stop alla rivalutazione

 

L’aderenza del paziente con malattia renale cronica e in dialisi. Esiti di interventi educativi. Il ruolo dell’Infermiere. Una revisione di revisioni – Rivista l’Infermiere N°4 – Formazione e Ricerca – FNOPI

RIASSUNTO Introduzione I pazienti con insufficienza renale all’ultimo stadio (ESKD) e con malattia renale cronica (CKD) sono esposti a fattori … Rivista L’Infermiere

Sorgente: L’aderenza del paziente con malattia renale cronica e in dialisi. Esiti di interventi educativi. Il ruolo dell’Infermiere. Una revisione di revisioni – Rivista l’Infermiere N°4 – Formazione e Ricerca – FNOPI

 
Lascia un commento

Pubblicato da su 14 dicembre 2018 in appopriatezza, farmacoeconomia, top

 

Tag: , ,

Under the cover of groceries: beating sugar taxes | The BMJ

A cynical strategy in the US to prevent local sugar taxes has had mixed results Sugar sweetened beverages provide empty calories that succeed in two ways: they make great profits for their manufacturers, and they fatten adults and children who drink them. Dozens of countries around the world and a few US cities have instituted taxes on sales of such drinks to discourage consumption and to raise funds for government health initiatives. Research is starting to accumulate showing that these excise taxes (often the equivalent of a penny or two per ounce at the wholesale level) reduce sales of sugary drinks and increase sales of those without sugar, such as bottled water.12 When I last wrote about this, in 2010,3 …

Sorgente: Under the cover of groceries: beating sugar taxes | The BMJ

 

Temporal trends in use of tests in UK primary care, 2000-15: retrospective analysis of 250 million tests | The BMJ

Objectives To assess the temporal change in test use in UK primary care and to identify tests with the greatest increase in use. Design Retrospective cohort study. Setting UK primary care. Participants All patients registered to UK General Practices in the Clinical Practice Research Datalink, 2000/1 to 2015/16. Main outcome measures Temporal trends in test use, and crude and age and sex standardised rates of total test use and of 44 specific tests. Results 262 974 099 tests were analysed over 71 436 331 person years. Age and sex adjusted use increased by 8.5% annually (95% confidence interval 7.6% to 9.4%); from 14 869 tests per 10 000 person years in 2000/1 to 49 267 in 2015/16, a 3.3-fold increase. Patients in 2015/16 had on average five tests per year, compared with 1.5 in 2000/1. Test use also increased statistically significantly across all age groups, in both sexes, across all test types (laboratory, imaging, and miscellaneous), and 40 of the 44 tests that were studied specifically. Conclusion Total test use has increased markedly over time, in both sexes, and across all age groups, test types (laboratory, imaging, and miscellaneous) and for 40 of 44 tests specifically

Sorgente: Temporal trends in use of tests in UK primary care, 2000-15: retrospective analysis of 250 million tests | The BMJ

 

Braced for Brexit | The BMJ

Se il Regno Unito lascia l’Unione Europea senza un accordo, le forniture di farmaci potrebbero affrontare “un momento catastrofico”, secondo Martin Sawer, direttore esecutivo della Healthcare Distribution Association.
Ma la Brexit non porta problemi. Dicono (in Italia)
Ricordo che il BMJ e’ l’organo ufficiale dell’ordine dei medici inglesi …

Availability of drugs—including blood products, insulin, and nuclear medicines—and treatment of rare diseases are some of the areas where uncertainty caused by UK-EU negotiations is increasingly concerning doctors, suppliers, and patients If the UK leaves the European Union without a deal in place, supplies of drugs could face “a catastrophic time,” according to Martin Sawer, executive director of the Healthcare Distribution Association. Two types at particular risk are insulin and biological medicines, including those derived from blood plasma—because the UK relies on imported supplies. The six week buffer stock that health secretary Matt Hancock has asked drug companies to set up in case of short term border disruption is straightforward (if costly) for drugs with a long shelf life. It is trickier for those that need to be kept at a controlled, low temperature during transport and storage. Mike Thompson, chief executive of the Association of the British Pharmaceutical Industry, told the Commons select committee no deal Brexit inquiry on 23 October1 that the government’s contingency plans were insufficient. There were no cold chain storage facilities at the ports in the event o

Sorgente: Braced for Brexit | The BMJ

 

Tag:

 
%d blogger hanno fatto clic su Mi Piace per questo: